Get the Stockscreener App
3.17
2.26%
0.07
After Hours:
3.16
-0.010
-0.32%
Achieve Life Sciences Inc stock is traded at $3.17, with a volume of 468.27K.
It is up +2.26% in the last 24 hours and up +2.92% over the past month.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
See More
Previous Close:
$3.10
Open:
$3.1
24h Volume:
468.27K
Relative Volume:
0.43
Market Cap:
$162.00M
Revenue:
-
Net Income/Loss:
$-32.94M
P/E Ratio:
-2.8559
EPS:
-1.11
Net Cash Flow:
$-24.95M
1W Performance:
-4.52%
1M Performance:
+2.92%
6M Performance:
+46.08%
1Y Performance:
-36.47%
1-Day Range:
$3.03
$3.19
1-Week Range:
$3.03
$3.475
52-Week Range:
$1.84
$5.31
Achieve Life Sciences Inc Stock (ACHV) Company Profile
Name
Achieve Life Sciences Inc
Sector
Industry
Phone
425-686-1500
Address
22722 29TH DR. SE, SEATTLE, BC
Compare ACHV with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACHV
Achieve Life Sciences Inc
|
3.17 | 158.43M | 0 | -32.94M | -24.95M | -1.11 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Achieve Life Sciences Inc Stock (ACHV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-21-25 | Initiated | H.C. Wainwright | Buy |
| Nov-14-24 | Initiated | Rodman & Renshaw | Buy |
| Sep-27-24 | Initiated | Raymond James | Strong Buy |
| May-10-23 | Reiterated | Maxim Group | Buy |
| Jun-23-21 | Initiated | Oppenheimer | Outperform |
Achieve Life Sciences Inc Stock (ACHV) Latest News
What machine learning models say about Achieve Life Sciences Inc.Portfolio Return Report & Community Trade Idea Sharing - newser.com
Advanced analytics toolkit walkthrough for Achieve Life Sciences Inc.July 2025 Closing Moves & Weekly Top Gainers Alerts - newser.com
Will Achieve Life Sciences Inc. stock continue dividend increases2025 Price Action Summary & Weekly Market Pulse Alerts - newser.com
Price momentum metrics for Achieve Life Sciences Inc. explainedQuarterly Profit Report & Real-Time Volume Analysis - newser.com
Using R and stats models for Achieve Life Sciences Inc. forecastingWeekly Market Report & AI Forecasted Entry/Exit Points - newser.com
Using AI based signals to follow Achieve Life Sciences Inc.2025 Trading Volume Trends & Stock Timing and Entry Methods - newser.com
Can Achieve Life Sciences Inc. (SP4P) stock stage a strong rebound this quarterStop Loss & High Accuracy Trade Signal Alerts - newser.com
Can Achieve Life Sciences Inc. stock deliver strong Q4 earningsNew Guidance & Safe Entry Point Alerts - newser.com
Using data models to predict Achieve Life Sciences Inc. stock movementJuly 2025 Selloffs & Detailed Earnings Play Strategies - newser.com
Ranking Achieve Life Sciences Inc. among high performing stocks via toolsWeekly Volume Report & Technical Pattern Recognition Alerts - newser.com
What momentum shifts mean for Achieve Life Sciences Inc.July 2025 Fed Impact & Weekly High Return Stock Forecasts - newser.com
Relative strength of Achieve Life Sciences Inc. in sector analysisWeekly Loss Report & Free Long-Term Investment Growth Plans - newser.com
Is Achieve Life Sciences Inc. meeting your algorithmic filter criteria2025 Top Decliners & Daily Entry Point Alerts - newser.com
How Achieve Life Sciences Inc. (SP4P) stock stacks up against competitorsJuly 2025 Summary & Precise Swing Trade Entry Alerts - newser.com
Is Achieve Life Sciences Inc a good long term investmentEarnings Call Summaries & Predict Volatility With Our Neural Network - earlytimes.in
What to expect from Achieve Life Sciences Inc. in the next 30 daysJuly 2025 Rallies & AI Powered Market Entry Strategies - newser.com
What earnings revisions data tells us about Achieve Life Sciences Inc.July 2025 News Drivers & Intraday High Probability Setup Alerts - newser.com
Recent uptick might appease Achieve Life Sciences, Inc. (NASDAQ:ACHV) institutional owners after losing 33% over the past year - simplywall.st
How forex fluctuations impact Achieve Life Sciences Inc. (SP4P) stockJuly 2025 Final Week & Weekly Setup with High ROI Potential - newser.com
Achieve Life Sciences' (ACHV) Sell (D-) Rating Reaffirmed at Weiss Ratings - MarketBeat
Achieve Life Sciences Announces Leadership Change - TipRanks
Achieve Life Sciences announces resignation of chief medical officer and president - Investing.com
Achieve Life Sciences (NASDAQ:ACHV) Stock Crosses Above 200-Day Moving AverageHere's What Happened - MarketBeat
Understanding Achieve Life Sciences Inc.’s price movementEarnings Performance Report & Safe Capital Growth Trade Ideas - newser.com
How Achieve Life Sciences Inc. (SP4P) stock compares with top peersMarket Movement Recap & Stepwise Trade Signal Implementation - newser.com
How to use Fibonacci retracement on Achieve Life Sciences Inc.2025 Analyst Calls & Risk Adjusted Swing Trade Ideas - newser.com
Custom strategy builders for tracking Achieve Life Sciences Inc.Market Risk Analysis & Long-Term Safe Investment Ideas - newser.com
Achieve Life Sciences Inc Stock (ACHV) Financials Data
Revenue
Net Income
Cash Flow
EPS
Achieve Life Sciences Inc Stock (ACHV) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Oki Mark K | Chief Financial Officer |
Sep 18 '25 |
Sale |
2.92 |
50,060 |
146,175 |
127,940 |
| Stewart Richard Alistair | Chief Executive Officer |
Sep 18 '25 |
Option Exercise |
0.00 |
297,500 |
0 |
358,376 |
| Stewart Richard Alistair | Chief Executive Officer |
Sep 18 '25 |
Sale |
2.92 |
129,501 |
378,143 |
228,875 |
| Wan Jerry | Principal Accounting Officer |
Sep 04 '25 |
Option Exercise |
0.00 |
34,100 |
0 |
46,764 |
| Wan Jerry | Principal Accounting Officer |
Sep 04 '25 |
Sale |
2.77 |
14,070 |
38,974 |
32,694 |
| KING THOMAS BRAXTON | Director |
Sep 04 '25 |
Option Exercise |
0.00 |
455,000 |
0 |
455,000 |
| KING THOMAS BRAXTON | Director |
Sep 04 '25 |
Sale |
2.77 |
139,858 |
387,407 |
315,142 |
| JACOBS CINDY | President & CMO |
Sep 04 '25 |
Option Exercise |
0.00 |
110,000 |
0 |
143,214 |
| JACOBS CINDY | President & CMO |
Sep 04 '25 |
Sale |
2.77 |
27,629 |
76,532 |
115,585 |
| Xinos Jaime | Chief Commercial Officer |
Sep 04 '25 |
Option Exercise |
0.00 |
69,000 |
0 |
95,286 |
5.15%
1.45%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):